ReviewAmerican journal of hematology2017
Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.
Armin Rashidi, Alaa M Ali, Kiran R Vij, Ryan Shanley, Rizwan Romee, Sarah A Cooley, Peter Westervelt, John F DiPersio, Jeffrey S Miller, Daniel J Weisdorf and 1 more
Abstract readLetterReview
In one paragraphReview in American journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Kiran R VijDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
Ryan ShanleyBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Rizwan RomeeDivision of Oncology, Washington University School of Medicine, Bone Marrow Transplantation and Leukemia, St. Louis, Missouri.
Sarah A CooleyDivision of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Peter WesterveltDivision of Oncology, Washington University School of Medicine, Bone Marrow Transplantation and Leukemia, St. Louis, Missouri.
John F DiPersioDivision of Oncology, Washington University School of Medicine, Bone Marrow Transplantation and Leukemia, St. Louis, Missouri.
Jeffrey S MillerDivision of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Daniel J WeisdorfDivision of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Funding
Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4MUniversity of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9MNCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationAdultAgedAllograftsAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCladribineCombined Modality TherapyCytarabineEtoposideFemaleFilgrastimHumansImmunosuppressive AgentsLeukemia, Myeloid, AcuteMaleCladribineCytarabineEtoposideFilgrastimImmunosuppressive AgentsMitoxantrone
Identifiers
PMID28568483
PMCPMC5736150
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390